BioCryst Pharmaceuticals
BCRX
#4939
Rank
A$2.84 B
Marketcap
A$11.05
Share price
-2.10%
Change (1 day)
2.70%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -A$0.51 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are A$0.96 Billion. In 2025 the company made an earning of A$0.39 Billion, an increase over its 2024 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.51 Billion-226.25%
2025 A$0.39 B-407.51%
2024 -A$0.13 Billion-61.56%
2023 -A$0.34 Billion-7.43%
2022 -A$0.37 Billion34.42%
2021 -A$0.27 Billion-0.55%
2020 -A$0.28 Billion67.88%
2019 -A$0.17 Billion7.55%
2018 -A$0.16 Billion53.92%
2017 -A$97.59 Million19.29%
2016 -A$81.81 Million28.19%
2015 -A$63.82 Million-4.8%
2014 -A$67.04 Million50.09%
2013 -A$44.67 Million-23.29%
2012 -A$58.23 Million-26.19%
2011 -A$78.89 Million54.78%
2010 -A$50.97 Million150.1%
2009 -A$20.38 Million-49.43%
2008 -A$40.3 Million14.07%
2007 -A$35.33 Million-49.31%
2006 -A$69.69 Million72.87%
2005 -A$40.32 Million22.08%
2004 -A$33.03 Million75.3%
2003 -A$18.84 Million-25.36%
2002 -A$25.24 Million225.05%
2001 -A$7.77 Million-56.6%
2000 -A$17.9 Million50.63%
1999 -A$11.88 Million38.05%
1998 -A$8.61 Million-52.46%
1997 -A$18.1 Million58.44%
1996 -A$11.43 Million-14.44%
1995 -A$13.36 Million28.57%
1994 -A$10.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-A$3.76 Billion 614.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.61 B-2,116.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.2 Billion-63.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$45.5 M-108.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.34 Billion-37.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.49 Billion-8.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$12.2 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$33.02 Million-93.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.29 Billion-45.14%๐Ÿ‡บ๐Ÿ‡ธ USA